Jim Simons Esperion Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q3 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 773,900 shares of ESPR stock, worth $2.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

773,900

Previous 292,400 164.67%

Holding current value

$2.24 Million

Previous $286,000 616.78%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$0.98 - $2.84 $471,870 - $1.37 Million	481,500 Added 164.67%	773,900 $2.05 Million
Q2 2025 Aug 13, 2025	BUY	$0.73 - $1.41 $213,452 - $412,284	292,400 New	292,400 $286,000
Q4 2024 Feb 13, 2025	SELL	$1.61 - $3.83 $539,833 - $1.28 Million	-335,300 Reduced 36.68%	578,800 $1.27 Million
Q3 2024 Nov 13, 2024	SELL	$1.61 - $2.73 $817,558 - $1.39 Million	-507,800 Reduced 35.71%	914,100 $1.51 Million
Q2 2024 Aug 09, 2024	SELL	$1.84 - $3.24 $1.28 Million - $2.25 Million	-694,600 Reduced 32.82%	1,421,900 $3.16 Million

Q1 2024 May 13, 2024	BUY	$2.02 - $3.02 $1.41 Million - $2.1 Million	696,400 Added 49.04%	2,116,500 $5.67 Million
Q4 2023 Feb 13, 2024	BUY	$0.73 - $3.08 $886,179 - $3.74 Million	1,213,944 Added 588.85%	1,420,100 $4.25 Million
Q3 2023 Nov 14, 2023	BUY	$0.96 - $1.79 $88,181 - $164,422	91,856 Added 80.36%	206,156 $202,000
Q2 2023 Aug 11, 2023	BUY	$1.2 - $1.76 $137,160 - $201,168	114,300 New	114,300 $159,000
Q3 2022 Nov 14, 2022	SELL	$5.45 - $8.13 $537,370 - $801,618	-98,600 Reduced 25.59%	286,700 $1.92 Million
Q2 2022 Aug 12, 2022	SELL	$4.77 - $6.67 $176,012 - $246,123	-36,900 Reduced 8.74%	385,300 $2.45 Million
Q1 2022 May 13, 2022	BUY	$3.34 - $5.56 $1.41 Million - $2.35 Million	422,200 New	422,200 $1.96 Million
Q4 2019 Feb 13, 2020	SELL	$35.4 - $59.82 $5.02 Million - $8.49 Million	-141,900 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$34.47 - $47.53 $3.3 Million - $4.54 Million	-95,600 Reduced 40.25%	141,900 $5.2 Million
Q2 2019 Aug 12, 2019	BUY	$40.1 - $52.33 $1.68 Million - $2.19 Million	41,905 Added 21.42%	237,500 $11 Million
Q1 2019 May 14, 2019	BUY	$40.11 - $53.57 $7.13 Million - $9.52 Million	177,695 Added 992.71%	195,595 $7.85 Million
Q4 2018 Feb 13, 2019	BUY	$36.99 - $59.11 $662,121 - $1.06 Million	17,900 New	17,900 $823,000

Others Institutions Holding ESPR

# of Institutions

214

Shares Held

114M

Call Options Held

643K

Put Options Held

769K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $193M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account